Patents Assigned to Mindset Pharma Inc.
  • INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
    Publication number: 20240166599
    Abstract: The present application relates to 3-amino-indole derivatives of general Formula (I-A), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptors in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses and CNS disorders.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 23, 2024
    Applicant: Mindset Pharma Inc.
    Inventors: Abdelmalik Slassi, Joseph Araujo, Guy Andrew Higgins
  • INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
    Publication number: 20240166630
    Abstract: The present application relates to 3-amino-indole derivatives of general Formula (I-B), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptors in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptors in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses and CNS disorders.
    Type: Application
    Filed: March 2, 2022
    Publication date: May 23, 2024
    Applicant: Mindset Pharma Inc.
    Inventors: Abdelmalik Slassi, Joseph Araujo, Guy Andrew Higgins
  • 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20240051978
    Abstract: The present application relates to 3-cyclic amine-indole derivatives of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, and treating diseases, disorders or conditions treatable by activation of a serotonin receptor in a cell. The diseases, disorders or conditions include, for example, psychosis and mental illness.
    Type: Application
    Filed: December 7, 2021
    Publication date: February 15, 2024
    Applicant: Mindset Pharma Inc.
    Inventors: Abdelmalik Slassi, Joseph Araujo, Guy Higgins
  • Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
    Patent number: 11597738
    Abstract: The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: March 7, 2023
    Assignee: MINDSET PHARMA INC.
    Inventors: Abdelmalik Slassi, Joseph Araujo
  • Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
    Patent number: 11591353
    Abstract: The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: February 28, 2023
    Assignee: Mindset Pharma Inc.
    Inventors: Abdelmalik Slassi, Joseph Araujo
  • 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
    Patent number: 11453689
    Abstract: The present application relates to 3-cyclic amine-indole derivatives of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses, and other neurological diseases, disorders and conditions.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: September 27, 2022
    Assignee: MINDSET PHARMA INC.
    Inventors: Abdelmalik Slassi, Joseph Araujo
  • Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
    Patent number: 11427604
    Abstract: The present application relates to psilocin derivatives of Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: August 30, 2022
    Assignee: Mindset Pharma Inc.
    Inventors: Abdelmalik Slassi, Joseph Araujo